Friday 19th August 2022

Category: Phase retrieval

Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for

[ad_1] Purpose: Increased prevalence of cytotoxic T lymphocytes (CTL) in the tumor microenvironment (TME) predicts positive outcomes in patients with epithelial ovarian cancer (EOC), whereas the re...

May 13th, 2022 by

NXT Energy Solutions Announces First Quarter 2022 Results

[ad_1] CALGARY, Alberta, May 12, 2022 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX: SFD; OTC QB: NSFDF) today announced the Company’...

May 12th, 2022 by

Alvopetro Announces Record First Quarter 2022 Results, an Operational Update, Additional

[ad_1] CALGARY, AB , May 12, 2022 /CNW/ – Alvopetro Energy Ltd. (TSXV: ALV) (OTCQX: ALVOF) announces record first quarter 2022 operating and financial results, an operational update, an addit...

May 12th, 2022 by

SIGILON THERAPEUTICS, INC. Management’s Discussion and Analysis of Financial Condition

[ad_1] The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and notes appearing elsewhere in this Q...

May 12th, 2022 by

Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides

[ad_1] CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its pro...

May 12th, 2022 by